Boring, sad... and painful!

Rukavishnikov G.V.

Рукавишников Г.В.

ФГБУ «Национальный медицинский центр психиатрии и неврологии им. В.М. Бехтерева» Минздрава России

ORCID: 0000-0002-5282-2036

И скучно, и грустно… и больно!

Авторы:

Рукавишников Г.В.

Подробнее об авторах

Журнал: Non nocere. Новый терапевтический журнал. 2025;(8): 56‑59

Прочитано: 120 раз

Связаться с автором

Оглавление

Как цитировать:

Рукавишников Г.В. И скучно, и грустно… и больно! Non nocere. Новый терапевтический журнал. 2025;(8):56‑59.
Rukavishnikov GV. Boring, sad... and painful$1 Non Nocere. New Therapeutic Journal. 2025;(8):56‑59. (In Russ.)

Использование инфографики авторами научных работ

Литература / References:

Institute of Health Metrics and Evaluation. Results from the 2021 Global Burden of Disease (GBD) study. https://vizhub.healthdata.org/gbd-results/
Berk M, Köhler-Forsberg O, Turner M, et al. Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. World Psychiatry. 2023 Oct;22(3):366-387. https://doi.org/10.1002/wps.21110
Arnaud AM, Brister TS, Duckworth K, et al. Impact of Major Depressive Disorder on Comorbidities: A Systematic Literature Review. J Clin Psychiatry. 2022 Oct 19;83(6):21r14328. https://doi.org/10.4088/JCP.21r14328
Rogers D, Pies R. General medical with depression drugs associated. Psychiatry (Edgmont). 2008 Dec;5(12):28-41.
Elgellaie A, Larkin T, Kaelle J, Mills J, Thomas S. Plasma prolactin is higher in major depressive disorder and females, and associated with anxiety, hostility, somatization, psychotic symptoms and heart rate. Compr Psychoneuroendocrinol. 2021 Mar 20;6:100049. https://doi.org/10.1016/j.cpnec.2021.100049
Hoare E, Collins S, Marx W, et al. Universal depression prevention: An umbrella review of meta-analyses. J Psychiatr Res. 2021 Dec;144:483-493. https://doi.org/10.1016/j.jpsychires.2021.10.006
Рукавишников Г.В., Кибитов А.О., Мазо Г.Э., Незнанов Н.Г. Генетическая детерминированность коморбидности депрессии и соматических заболеваний. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(1):89-96. https://doi.org/10.17116/jnevro201911901189
Rousset L, Halioua B. Stress and psoriasis. Int J Dermatol. 2018 Oct;57(10):1165-1172. https://doi.org/10.1111/ijd.14032
Meng X, Brunet A, Turecki G, et al. Risk factor modifications and depression incidence: a 4-year longitudinal Canadian cohort of the Montreal Catchment Area Study. BMJ Open. 2017;7:e015156. https://doi.org/10.1136/bmjopen-2016-015156
Alshaya DS. Genetic and epigenetic factors associated with depression: An updated overview. Saudi J Biol Sci. 2022 Aug;29(8):103311. https://doi.org/10.1016/j.sjbs.2022.103311
Czarny P, Wigner P, Galecki P, Sliwinski T. The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt C):309-321. https://doi.org/10.1016/j.pnpbp.2017.06.036
Kumar A, Pramanik J, Goyal N, et al. Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options. Pharmaceuticals (Basel). 2023 Apr 9;16(4):565. https://doi.org/10.3390/ph16040565
Hermesdorf M, Berger K, Baune BT, Wellmann J, Ruscheweyh R, Wersching H. Pain Sensitivity in Patients With Major Depression: Differential Effect of Pain Sensitivity Measures, Somatic Cofactors, and Disease Characteristics. J Pain. 2016 May;17(5):606-616. https://doi.org/10.1016/j.jpain.2016.01.474
Trivedi MH. The link between depression and physical symptoms. Prim Care Companion J Clin Psychiatry. 2004;6(Suppl 1):12-16.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
Самушия М.А., Аль-Шукри А.С., Баранов И.И. и др. Разработка алгоритма диагностики и лечения тревоги, ассоциированной с соматической патологией, у пациентов в общеклинической практике. Резолюция совета экспертов. Журнал неврологии и психиатрии им. С.С. Корсакова. 2025;125(1):62-69. https://doi.org/10.17116/jnevro202512501162
Bekhuis E, Boschloo L, Rosmalen JG, Schoevers RA. Differential associations of specific depressive and anxiety disorders with somatic symptoms. J Psychosom Res. 2015 Feb;78(2):116-122. https://doi.org/10.1016/j.jpsychores.2014.11.007
Alblooshi S, Taylor M, Gill N. Does menopause elevate the risk for developing depression and anxiety? Results from a systematic review. Australas Psychiatry. 2023 Apr;31(2):165-173. https://doi.org/10.1177/10398562231165439
Antonelli A, Giannini A, Chedraui P, et al. Mood disorders and hormonal status across women’s life: a narrative review. Gynecol Endocrinol. 2022 Dec;38(12):1019-1027. https://doi.org/10.1080/09513590.2022.2149730
Parissis J, Fountoulaki K, Paraskevaidis I, Kremastinos DT. Sertraline for the treatment of depression in coronary artery disease and heart failure. Expert Opin Pharmacother. 2007 Jul;8(10):1529-1537. https://doi.org/10.1517/14656566.8.10.1529
Gao SY, Wu QJ, Sun C, et al. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med. 2018 Nov 12;16(1):205. https://doi.org/10.1186/s12916-018-1193-5
Meyerowitz W, Jaramillo JDC. Sertraline treatment and weight loss. Current Therapeutic Research. 1994;55(10):1176-1181. https://doi.org/10.1016/S0011-393X(05)80258-9